Leukemia: all 5,475 studies

Page 55 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.

• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaCompletedNCT00002868Phase 3
• High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaCompletedNCT00002865Phase 2
• Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00002844Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaCompletedNCT00002838Phase 1/2
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaCompletedNCT00002833Phase 2
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00002832Phase 1/2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute LeukemiaCompletedNCT00002831Phase 1/2
• High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesCompletedNCT00002818Phase 1
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00002816Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaCompletedNCT00002812Phase 3
• Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerCompletedNCT00002809Phase 2
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002800Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWithdrawnNCT00002790Phase 1/2
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid LeukemiaCompletedNCT00002789Phase 3
• High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00002788Phase 1
• Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00002785Phase 2
• Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00002778Phase 2
• Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaStatus unknownNCT00002771Phase 3
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionCompletedNCT00002768Phase 2
• Immunotoxin in Treating Patients With Leukemia or LymphomaCompletedNCT00002765Phase 1
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaWithdrawnNCT00002761Phase 1/2
• TITLE:Less Intensive Therapy for Children With Non-Hodgkin's LymphomaCompletedNCT00002757Phase 3
• Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002756Phase 2
• Melphalan in Patients With Neoplastic MeningitisCompletedNCT00002750Phase 1
• Interleukin-2 in Treating Patients With Myelodysplastic SyndromeCompletedNCT00002746Phase 1
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002744Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's LymphomaCompletedNCT00002738Phase 2
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00002719Phase 3
• T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
• Topotecan in Treating Children With Refractory LeukemiaCompletedNCT00002705Phase 1
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic LeukemiaStatus unknownNCT00002701Phase 3
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic LeukemiaCompletedNCT00002700Phase 3
• Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute LeukemiaCompletedNCT00002693Phase 1
• Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT00002688Phase 2
• Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or LymphomaCompletedNCT00002681Phase 1/2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002674Phase 2
• SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic LeukemiaCompletedNCT00002665Phase 2
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid LeukemiaStatus unknownNCT00002658Phase 3
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic LeukemiaCompletedNCT00002638Phase 2
• Interferon Alfa in Treating Children With HIV-Related CancerCompletedNCT00002621Phase 2
• Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in RemissionCompletedNCT00002609Phase 2
• Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002598Phase 2
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002592Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory LeukemiaCompletedNCT00002588Phase 1
• Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002574Phase 2
• High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in RemissionCompletedNCT00002567Phase 2
• Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First RelapseCompletedNCT00002554Phase 2
• Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic CancerCompletedNCT00002553Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaStatus unknownNCT00002549Phase 3
• Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic SyndromeCompletedNCT00002547Phase 2
• Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second RemissionCompletedNCT00002534Phase 3
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaStatus unknownNCT00002532Phase 2
• Combination Chemotherapy in Treating Adults With Acute Lymphocytic LeukemiaStatus unknownNCT00002531Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002517Phase 3
• Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedNCT00002514Phase 3
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerCompletedNCT00002504Phase 2
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic LeukemiaStatus unknownNCT00002499Phase 2/3
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00002494Phase 2
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT00002485
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaCompletedNCT00002471Phase 2
• Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationCompletedNCT00002456Phase 3
• The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersCompletedNCT00001873Phase 2
• Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsCompletedNCT00001830Phase 1
• HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesCompletedNCT00001748Phase 1
• A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With LeukemiaCompletedNCT00001689Phase 1
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older AdultsCompletedNCT00001637Phase 2
• Bone Marrow Transplant Studies for Safe and Effective Treatment of LeukemiaCompletedNCT00001623Not applicable
• A Phase II Efficacy Study of Roferon-A in Hairy Cell LeukemiaCompletedNCT00001567Phase 2
• Phase I Study of Intrathecal MafosfamideCompletedNCT00001251Phase 1
• Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-TacCompletedNCT00001249Phase 1
• Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous LeukemiaCompletedNCT00001144Phase 2

← Leukemia overview